Menu
Home
About Us
About 340B Report
Who We Are
Testimonials
Sample Issue
Subscribe
Contact
Subscriber FAQ
Sponsor/Advertise
Why Sponsor?
Podcast
Resource Center
Document Center
Special Reports
Webinars
Article Archives
340B Leaders
Industry Insights
Spotlights
340B Industry Leaders
340B Provider Leaders
Our Sponsors
Expert Directory
Expert Tips
Events Calendar
340B Trackers
Contract Pharmacy Restrictions Tracker
State Contract Pharmacy Bills & Laws
State Provider Reporting Bills & Laws
State PBM Reimbursement Laws
Drugmaker State Exemptions Tracker
Congressional 340B Bill Tracker
Subscribe
Sign in
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
340B Report
Aranesp is among the drugs listed on HRSA's latest manufacturer's notice posted on behalf of Amgen.
Amgen, Vertex, and AstraZeneca Post 340B Refund and Replenishment Public Notices
July 27, 2023
Tom Mirga, Editor at Large
Views
The U.S. Health Resources and Services Administration (HRSA) this week published notices from drug makers Amgen and Vertex about refunds [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
Please be sure you’ve completed your
one-minute subscription completion form
.
I have read and accepted the
terms of use
and
privacy policy
.
Log In!
If you are not yet a paid subscriber, please
Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at
reshma.eggleston@340breport.com
.
Tom Mirga